Enhanced insulin-like growth factor-1 (IGF-1) cell association at reduced pH is dependent on IGF binding protein-3 (IGFBP-3) interaction

Journal of Cellular Physiology

Volumn 210, Issue 2, 2007, Pages 298-308

  Forsten Williams, Kimberly ^a,b   Cassino, Theresa R ^a,b   Delo, Laura J ^a   Bellis, Abigail D ^a   Robinson, Anne S ^c   Ryan, Thomas E ^d  

^a State University   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c University of Delaware   (United States)

^d Reichert Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LEUCINE; MUTANT PROTEIN; PROTEIN LONG R3 IGF 1; PROTEIN Y60L IGF 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TYLOXAPOL; TYROSINE;

ACIDOSIS; ANIMAL CELL; ARTICLE; BINDING KINETICS; BINDING SITE; CELL ADHESION; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; MICROENVIRONMENT; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR SOLUBILIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

ANIMALS; BINDING SITES; CATTLE; CELL AGGREGATION; CELL LINE; HYDROGEN-ION CONCENTRATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KINETICS; MACROMOLECULAR SUBSTANCES; MUTATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; SOLUBILITY; SURFACE PROPERTIES;

EID: 33845654876     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20849     Document Type: Article

References (52)

1. Bach LA, Headey SJ, Norton RS. 2005. IGF-binding proteins-The pieces are falling into place. Trends Endocrinol Metab 16;228-234.
2. Bayne ML, Applebaum J, Chicchi GG, Miller RE, Cascieri MA. 1990. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. J Biol Chem 265: 15648-15652.
3. Beattie J, Phillips K, Shand JH, Szymanowska M, Flint DJ, Allan GJ. 2005. Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein-3/5 (IGFBP-3/5) heparin axis. J Mol Endocrinol 34:163-175.
4. Bellocq A, Suberville S, Philippe C, Bertrand F, Perez J, Fouqueray B, Cherqui G, Baud L. 1998. Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-kappaB activation. J Biol Chem 273:5086-5092.
5. Burrows C, Holly JM, Laurence NJ, Vernon EG, Carter JV, Clark MA, McIntosh J, McCaig C, Winters ZE, Perks CM. 2006. Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes. Endocrinology 47:3484-3500.
6. Chang SY, Ko HJ, Heo TH, Kang CY. 2005. Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH. Mol Pharmacol 67;1534-1543.
7. Dubaquié Y, Lowman H. 1999. Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3. Biochemistry 38:6386-6396.
8. Engin K, Leeper DB, Cater JK, Thistlethwaite AJ, Tupchong L, McFarlane JD. 1995. Extracellular pH distribution in human tumours. Int J Hyperthermia 11:211-216.
9. Firth SM, Ganeshprasad U, Baxter RC. 1998. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3. J Biol Chem 273:2631-2638.
10. Fong CC, Wong MS, Fong WF, Yang M. 2002. Effect of hydrogel matrix on binding kinetics of protein-protein interaction on sensor surface. Analytica Chimica Acta 456:201-208.
11. Forsten KE, Akers RM, San Antonio JD. 2001. Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment. J Cell Physiol 189:356-365.
12. Galanis M, Firth SM, Bond J, Nathanielsz A, Kortt AA, Hudson PJ, Baxter RC. 2001. Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3. J Endocrinol 169:123-133.
13. Gerweck LE, Seetharaman K. 1996. Cellular pH gradient in tumor versus normal tissue: Potential exploitation for the treatment of cancer. Cancer Res 56:1194.
14. Gill ZP, Perks CM, Newcomb PV, Holly JMP. 1997. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J Biol Chem 272:25602-25607.
15. Gillard M, Chatelain P. 2006. Changes in pH differently affect the binding properties of histamine H(1) receptor antagonists. Eur J Pharmacol 530:205-214.
16. Goerges AL, Nugent MA. 2003. Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem 278:19518-19525.
17. Goerges AL, Nugent MA. 2004. pH regulates vascular endothelial growth factor binding to fibronectin: A mechanism for control of extracellular matrix storage and release. J Biol Chem 279:2307-2315.
18. Gopalakrishnan M, Forsten-Williams K, Cassino TR, Padro L, Ryan TE, Tauber UC. 2005. Ligand rebinding: Self-consistent mean-field theory and numerical simulations applied to surface plasmon resonance studies. Eur Biophys J 34:943-958.
19. Grill CJ, Cohick WS. 2000. Insulin-like growth factor binding protein-3 mediates IGF-I action in a bovine mammary epithelial cell line independent of an IGF interaction. J Cell Physiol 183:273-283.
20. Grill CJ, Sivaprasad U, Cohick WS. 2002. Constitutive expression of IGF-binding protein-3 by mammary epithelial cells alters signaling through Akt and p70S6 kinase. J Mol Endocrinol 29:153-162.
21. Heding A, Gill R, Ogawa Y, DeMeyts P, Shymko RM. 1996. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3. J Biol Chem 271:13948-13952.
22. Hobba GD, Lothgren A, Holmberg E, Forbes BE, Francis GL, Wallace JC. 1998. Alanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding. J Biol Chem 273:19691-19698.
23. Hong S, Huo H, Xu J, Liao K. 2004. Insulin-like growth factor-1 receptor signaling in 3T3-L1 adipocyte differentiation requires lipid rafts but not caveolae. Cl1 Death Differ 11:714-723.
24. Hooper NM. 1999. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae. Mol Membr Biol 16:145-156.
25. Kani K, Park E, Landgraf R. 2005. The extracellular domains of ErbBS retain high ligand binding affinity at endosome pH and in the locked conformation. Biochemistry 44:15842-15857.
26. Lahiri J, Isaacs L, Tien J, Whitesides GM. 1999. A strategy for the generation of surfaces presenting ligands for studies of binding based on an active ester as a common reactive intermediate: A surface plasmon resonance study. Anal Chem 71:777-790.
27. Lee KW, Liu B, Ma L, Li H, Bang P, Koeffler HP, Cohen P. 2004. Cellular internalization of insulin-like growth factor binding protein-3: Distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279:469-476.
28. Libby P. 2002. Inflammation in atherosclerosis. Nature 420:868-874.
29. Ling T-Y, Chen C-L, Huang Y-H, Liu I-H, Huang SS, Huang JS. 2004. Identification and characterization of the acidic pH binding sites for growth regulatory ligands of low density lipoprotein receptor-related protein-1. J Biol Chem 279:38736-38748.
30. Liu BR, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P. 2000. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 275:33607-33613.
31. Liu B, Weinzimer SA, Gibson TB, Mascarenhas D, Cohen P. 2003. Type Ialpha collagen is an IGFBP-3 binding protein. Growth Horm IGF Res 13:89-97.
32. Magee BA, Shooter GK, Wallace JC, Francis GL. 1999. Insulin-like growth factor I and its binding proteins: A study of the binding interface using B-domain analogues. Biochemistry 38:15863-15870.
33. Martin JL, Jambazov S. 2006. Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/p42 MAPK. Endocrinology 147:4400-4409.
34. Martin JA, Miller BA, Scherb MB, Lembke LA, Buckwalter JA. 2002. Colocalization of insulin-like growth factor binding protein 3 and fibronectin in human articular cartilage. Osteoarthritis Cartilage 10:556-563.
35. Matthews LC, Taggart MJ, Westwood M. 2005. Effect of cholesterol depletion on mitogenesis and survival: The role of caveolar and noncaveolar domains in insulin-like growth factor-mediated cellular function. Endocrinology 146: 5463-5473.
36. Maurice P, Waeckel L, Pires V, Sonnet P, Lemesle M, Arbeille B, Vassy J, Rochette J, Legrand C, Fauvel-Lafeve F. 2006. The platelet receptor for type III collagen (TIIICBP) is present in platelet membrane lipid microdomains (rafts). Histochem Cell Biol 125:407-417.
37. Paye JMD, Forsten-Williams K. 2006. Regulation of insulin-like growth factor-I (IGF-I) delivery by IGF binding proteins and receptors" Ann Biomed Eng 34:618-632.
38. Podar K, Tai YT, Cole CE, Hideshima T, Sattler M, Hamblin A, Mitsiades N, Schlossman RL, Davies FE, Morgan GJ, Munshi NC, Chauhan D, Anderson KC. 2003. Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. J Biol Chem 278:5794-5801.
39. Rajah R, Valentinis B, Cohen P. 1997. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272:12181-12188.
40. Rao BM, Driver I, Lauffenburger DA, Wittrup KD. 2004. Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect. Mol Pharmacol 66:864-869.
41. Remacle-Bonnet M, Garrouste F, Baillat G, Andre F, Marvaldi J, Pommier G. 2005. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily. Am J Pathol 167:761-773.
42. Robinson SA, Rosenzweig SA. 2004. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: Topographical evaluation of the IGF-1/IGFBP-2 and IGFBP-3 interface. Biochemistry 43:11533-11545.
43. Sethuraman VA, Na K, Bae YH. 2006. pH-responsive sulfonamide/PEI system for tumor specific gene delivery: An in vitro study. Biomacromolecules 7:64-70.
44. Shand JH, Beattie J, Song H, Phillips K, Kelly SM, Flint DJ, Allan GJ. 2003. Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I. J Biol Chem 278:17859-17866.
45. Shi Z, Xu W, Loechel F, Wewer UM, Murphy LJ. 2000. ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3. J Biol Chem 275:18574-18580.
46. Sneck M, Kovanen PT, Oorni K. 2005. Decrease in pH strongly enhances binding of native, proteolyzed, lipolyzed, and oxidized low density lipoprotein particles to human aortic proteoglycans. J Biol Chem 280:37449-37454.
47. Trevani AS, Andonegui G, Giordano M, López DH, Gamberale R, Minucci F, Geffner JR. 1999. Extracellular acidification induces human neutrophil activation. J Immunol 162:4849-4857.
48. Vermeulen M, Giordano M, Trevani AS, Sedlik C, Gamberale R, Fernandez-Calotti P, Salamone G, Raiden S, Sanjurjo J, Geffner JR. 2004. Acidosis improves uptake of antigens and MHC class I-restricted presentation by dendritic cells. J Immunol 172:3196-3204.
49. Vorwerk P, Hohmann B, Oh Y, Rosenfeld RG, Shymko RM. 2002. Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor. Endocrinology 143:1677-1685.
50. Wong MS, Fong CC, Yang M. 1999. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins. Biochim Biophys Acta 1432:293-301.
51. Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM. 2004. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation. J Biol Chem 279: 53232-53240.
52. Zwad O, Kubler B, Roth W, Scharf JG, Saftig P, Peters C, Braulke T. 2002. Decreased intracellular degradation of insulin-like growth factor binding protein-3 in cathepsin L-deficient fibroblasts. FEES Lett 510:211-215.